First international consensus guidelines for breast cancer in young women (BCY1)
- 23 April 2014
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 23 (3), 209-220
- https://doi.org/10.1016/j.breast.2014.03.011
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2011
- The Impact of Age on Outcome in Early-Stage Breast CancerSeminars in Radiation Oncology, 2010
- Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialBreast Cancer Research and Treatment, 2010
- Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialThe Breast, 2010
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysisEuropean Journal Of Cancer, 2010
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersBreast Cancer Research and Treatment, 2010
- Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancerBreast Cancer Research and Treatment, 2010
- Contraception for Cancer SurvivorsJournal of General Internal Medicine, 2009